首站-论文投稿智能助手
典型文献
Scutellarin suppresses triple-negative breast cancer metastasis by inhibiting TNFα-induced vascular endothelial barrier breakdown
文献摘要:
Triple-negative breast cancer(TNBC)is an aggressive subtype of breast cancer with high vascularity and frequent metastasis.Tumor-associated abnormal vasculature was reported to accelerate TNBC metastasis.Scutellarin(SC)is a natural flavonoid with a cardiovascular protective function.In this study,SC reduced TNBC metastasis and alleviated tumor-associated vascular endothelial barrier injury in vivo.SC rescued the tumor necrosis factor-α(TNFα)-induced diminishment of endothelial junctional proteins and dysfunction of the endothelial barrier in vitro.SC reduced the increased transendothelial migration of TNBC cells through a monolayer composed of TNFα-stimulated human mammary microvascular endothelial cells(HMMECs)or human umbilical vein endothelial cells(HUVECs).TNFα induced the nuclear translocation of enhancer of zeste homolog-2(EZH2),and its chemical inhibitor GSK126 blocked TNFα-induced endothelial barrier disruption and subsequent TNBC transendothelial migration.TNF receptor 2(TNFR2)is the main receptor by which TNFα regulates endothelial barrier breakdown.Extracellular signal-regulated protein kinase(ERK)1/2 was found to be downstream of TNFα/TNFR2 and upstream of EZH2.Additionally,SC abrogated the TNFR2-ERK1/2-EZH2 signaling axis both in vivo and in vitro.Our results suggest that SC reduced TNBC metastasis by suppressing TNFα-initiated vascular endothelial barrier breakdown through rescuing the reduced expression of junctional proteins by regulating the TNFR2-ERK1/2-EZH2 signaling pathway.
文献关键词:
作者姓名:
Xi-yu Mei;Jing-nan Zhang;Wang-ya Jia;Bin Lu;Meng-na Wang;Tian-yu Zhang;Li-li Ji
作者机构:
The MOE Key Laboratory for Standardization of Chinese Medicines,Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines,Institute of Chinese Materia Medica,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China
引用格式:
[1]Xi-yu Mei;Jing-nan Zhang;Wang-ya Jia;Bin Lu;Meng-na Wang;Tian-yu Zhang;Li-li Ji-.Scutellarin suppresses triple-negative breast cancer metastasis by inhibiting TNFα-induced vascular endothelial barrier breakdown)[J].中国药理学报(英文版),2022(10):2666-2677
A类:
Scutellarin,diminishment,transendothelial,HMMECs
B类:
suppresses,triple,negative,breast,cancer,metastasis,by,inhibiting,induced,barrier,breakdown,Triple,TNBC,aggressive,subtype,high,vascularity,frequent,Tumor,associated,abnormal,vasculature,was,reported,accelerate,SC,natural,flavonoid,cardiovascular,protective,In,this,study,reduced,alleviated,tumor,injury,vivo,rescued,necrosis,junctional,proteins,dysfunction,vitro,increased,migration,cells,through,monolayer,composed,stimulated,human,mammary,microvascular,umbilical,vein,HUVECs,nuclear,translocation,enhancer,zeste,homolog,EZH2,its,chemical,inhibitor,GSK126,blocked,disruption,subsequent,receptor,TNFR2,main,which,regulates,Extracellular,regulated,kinase,found,be,downstream,upstream,Additionally,abrogated,ERK1,signaling,axis,both,Our,results,suggest,that,suppressing,initiated,rescuing,expression,regulating,pathway
AB值:
0.502391
相似文献
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
Yanghe decoction(阳和汤)attenuated pain hypersensitivity induced by michigan cancer foundation-7 injection in rats with bone metastases from breast cancer by inhibiting transient receptor potential ankyrin 1
GONG Hui;LI Yang;FENG Lei;XIAO Yujie;HUANG Lizhong;MAO Dan;ZHANG Hui-Department of Medical Oncology,Hunan Academy of Traditional Chinese Medicine Affiliated Hospital,Changsha 410006,China;Department of Medical Oncology,Hunan Cancer Hospital,Changsha 410031,China;Department of Medical Oncology,Hunan University of Chinese Medicine,Changsha 410208,China;Department of Integrated Traditional Chinese and Western Medicine,the Second Xiangya Hospital,Central South University,Changsha 410011,Changsha,China;Department of Medical Oncology,Hainan Hospital of Traditional Chinese Medicine,Haikou 570203,China
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis
Xingyan Zhang;Xiaoyan Lian;Huling Li;Wenjing Zhao;Xin Li;Fujun Zhou;Yutong Zhou;Tao Cui;Yuli Wang;Changxiao Liu-Key Laboratory of Quality-marker of Traditional Chinese Medicines,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;Department of Pharmacology,Tianjin Medical University,Tianjin 300070,China;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Key Laboratory of Systems Bioengineering(Ministry of Education),School of Chemistry Engineering and Technology,Tianjin University,Tianjin 300072,China;Pharmaceuticai Armaceuticai DA REN TANG Group Corporation Limited Traditional Chinese Pharmacy Researchinstitute,Tianjin 300457,China;Tianjin Key Laboratory of Quality Control in Chinese Medicine,Tianjin 300457,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Beijing 100730,China
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Lenvatinib-and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer
Chao Zheng;Wen Zhang;Jinming Wang;Yihui Zhai;Fengqin Xiong;Ying Cai;Xiang Gong;Binyu Zhu;Helen He Zhu;Hao Wang;Yaping Li;Pengcheng Zhang-China State Institute of Pharmaceutical Industry,Shanghai 201203,China;State Key Laboratory of Drug Research&Center of Pharmaceutics,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;State Key Laboratory of Oncogenes and Related Genes,Renji-Med-X Stem Cell Research Center,Department of Urology,Ren Ji Hospital,School of Medicine and School of Biomedical Engineering,Shanghai Jiao Tong University,Shanghai 200135,China;University of Chinese Academy of Sciences,Beijing 100049,China;Bohai Rim Advanced Research Institute for Drug Discovery,Yantai 264000,China;Yantai Key Laboratory of Nanomedicine&Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。